Orgenesis Inc Asset Turnover Ratio (ORGS), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Orgenesis Inc   (ORGS)
 

Orgenesis Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Orgenesis Inc asset turnover ratio, the ability of Orgenesis Inc 's assets to generate revenue in the fourth quarter 2024, increased sequentially to 0.04 in the fourth quarter (Dec 31 2024), yet the ratio remained below the average, as ORGS's position remain challenging.

Within sector 80 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the IV Quarter 2024, to 2330, from total ranking in the third quarter 2024 at 3527.

Asset Turnover Ratio Definition



ORGS Asset Turnover Ratio (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Asset Change -90.72 % 66.36 % 60.28 % -58.08 % -83.91 %
Y / Y Revenue Change 82.42 % 215.45 % 117.7 % -0.7 % -98.79 %
Asset Turnover Ratio (TTM) 0.04 0.03 0.03 0.03 0.02
ORGS's Total Ranking # 2330 # 3527 # 3503 # 3618 # 3131
Seq. Asset Change -95.38 % -4.46 % -1.13 % 112.42 % -17.09 %
Seq. Revenue Change -13.26 % 41.06 % 74.47 % -14.55 % 50 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 81
Healthcare Sector # 282
Overall Market # 2330

Asset Turnover Ratio Statistics
High Average Low
8.95 3.73 0.1
(Feb 28 2017)   (Dec 31 2023)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Assets at quarter ending Dec 31 2024
Sbc Medical Group Holdings Incorporated  2.08 $ 312.961  Millions$ 150.459  Millions
Integrated Biopharma Inc  1.98 $ 52.074  Millions$ 26.248  Millions
Avricore Health Inc   1.95 $ 3.440  Millions$ 1.761  Millions
Atara Biotherapeutics Inc   1.95 $ 259.990  Millions$ 133.590  Millions
Psychemedics Corporation  1.94 $ 19.101  Millions$ 9.855  Millions
Nature s Sunshine Products inc   1.87 $ 453.688  Millions$ 242.322  Millions
Medinotec Inc   1.86 $ 8.947  Millions$ 4.807  Millions
Rockwell Medical inc   1.84 $ 101.484  Millions$ 55.011  Millions
Cv Sciences Inc   1.80 $ 15.168  Millions$ 8.417  Millions
P3 Health Partners Inc   1.78 $ 1,500.455  Millions$ 841.359  Millions
Quipt Home Medical Corp   1.74 $ 429.306  Millions$ 246.220  Millions
Encision Inc   1.73 $ 6.496  Millions$ 3.753  Millions
Sunlink Health Systems Inc   1.72 $ 31.927  Millions$ 18.564  Millions
International Stem Cell Corporation  1.70 $ 9.085  Millions$ 5.329  Millions
Progyny Inc   1.69 $ 1,166.363  Millions$ 690.003  Millions
Regen Biopharma Inc   1.67 $ 0.264  Millions$ 0.158  Millions
Theratechnologies Inc   1.61 $ 85.866  Millions$ 53.340  Millions
Aspira Women s Health inc   1.59 $ 8.479  Millions$ 5.344  Millions
Privia Health Group Inc   1.58 $ 1,736.390  Millions$ 1,097.639  Millions
Vycor Medical Inc   1.57 $ 1.589  Millions$ 1.010  Millions
Iridex Corp  1.56 $ 48.502  Millions$ 31.158  Millions
Aesthetic Medical International Holdings Group Limited  1.55 $ 112.161  Millions$ 72.204  Millions
Zynex inc   1.55 $ 192.405  Millions$ 124.070  Millions
Innovage Holding Corp   1.52 $ 806.613  Millions$ 531.880  Millions
Kewaunee Scientific Corporation  1.49 $ 219.459  Millions$ 147.603  Millions
Option Care Health Inc   1.49 $ 4,998.202  Millions$ 3,361.906  Millions
Marpai Inc  1.45 $ 27.977  Millions$ 19.229  Millions
Mimedx Group Inc   1.45 $ 346.715  Millions$ 239.918  Millions
Myomo Inc   1.41 $ 32.185  Millions$ 22.817  Millions
Chemed Corporation  1.41 $ 2,431.287  Millions$ 1,725.157  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.